chartexchange

Bayer AG (BAYRY) (Q3 2026) Earnings Call Highlights: Raised Full-Year Outlook on Pharma ...

GuruFocus | Nov 3, 2026 4:05 PM EST

Bayer AG (BAYRY) lifted its 2026 adjusted EBITDA, free cash flow and net debt guidance as Nubeqa and Kerendia momentum offset Crop Science and Consumer Health headwinds. Related Stocks: BAYRY ,

Read original article